The market has already priced in SPNS's positive outlook. However, the stock's volatility could present a future buying opportunity. The company's optimistic future earnings growth should lead to robust cash flows, boosting share value.
Sapiens International's high P/E ratio is likely due to investors' expectations of strong future growth. The potential for a deterioration in earnings is not considered significant enough to justify a lower P/E ratio.
Sapiens International's increasing returns on capital and consistent reinvestment are highly desirable traits. Given its exceptional performance in the past five years, this stock warrants further investigation for a potentially bright future.
Sapiens International shows potential as a growth bet given its fast earnings growth and substantial insider ownership. Still, more analysis is needed before conclusions are drawn. Confidence may rise if more insiders buy shares.
Sapiens International's high beta may offer a buying opportunity in a bearish market. Its 27% profit growth expectation and subsequent higher cash flow could lead to a higher share valuation.
Sapiens International股票讨论区
1992年上市的以色列公司(第一大股东Formula Systems持股43.62%,也是家以色列软件解决方案公司),主要做保险行业的软件解决方案业务,主要市场在欧洲和美国,当前价格32.68。
5年来营收,营业利润,净利润均持续增长,近4年平均增速分别为12.1%,20%和24%,2023年增速下降到8.4%,18.6%和18.8%。2023年开始利息费用转为利息收入。毛利率近5年从39.8%提升到42.7%,净利率从8.1%提升到12.2%,净资产收益率从12.4%提升到14.7%。
5年来资产负债率从50.2%下降到34.8%,总资产和净资产均有大幅提升。 应收的比例和增速比较正常,商誉及其他无形资产 3.17亿,占4.5亿净资产的70.4%,长期借款0.4亿,杠杆率很低。
5年来现金流经营净额累计高于投资净额,产生了股东盈余。
目前市盈率29.4,估值在合理区间,暂时缺乏吸引力。
2022前三季度营收增长4%,营业利润增长20%,净利润增长17%。
利润表显示利息费用占营业利润的5%,负担很轻。
自从负债率5年来从46.2%上升到50%后又降回了42.8%,2022Q3降为41.3%。
应收款项占比和增长都比较正常,但是商誉3.15亿,占总资产的近1半,资产的含金量较低。
长期借款5,925.1万,占净资产的16%,杠杆率比较正常。
5年来经营净额低于投资净额,还未产生股东盈余。
目前20倍市盈率TTM,可以谨慎选择(⭐️)
today? $微美全息(WIMI.US)$
预计明年加息造成股市下跌,正式开启加息估计还会再掉一波🤔。我打算慢慢开始把一些股票清仓,存点现金不然到时没钱捡便宜🤑。
$iShares罗素2000指数ETF(IWM.US)$ $道琼斯指数(.DJI.US)$ $标普500指数(.SPX.US)$ $纳斯达克综合指数(.IXIC.US)$
暂无评论